Abnormal CacyBP/SIP levels have been found in pancreatic cancer, gastric cancer, colorectal cancer, osteogenic sarcoma, melanoma, kidney cancer, breast cancer, brain cancer (16). This evidence concerns the gene CACYBP and kidney cancer.